← Open Payments lookup

KERSEY FADDUOL: Open Payments

NPI 1730838400 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,008 in 47 payments from 9 companies in 2025. Trend: 2023 $21 · 2024 $695 · 2025 $1,008

Food & beverage: $1,008
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.15$266
Novo Nordisk Inc10$229
Lilly USA, LLC6$142
Exeltis, USA Inc.5$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$72
Amgen Inc.3$71
VERTEX PHARMACEUTICALS INCORPORATED2$60
MILLICENT US INC2$36
Cepheid1$23

Products named: MYFEMBREE, MOUNJARO, Wegovy, SLYND, XIFAXAN, EVENITY, Ozempic, Saxenda.

Industry payments across CA — which companies pay providers there.